Rockwell Medical, Inc. Profile Avatar - Palmy Investing

Rockwell Medical, Inc.

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the Unite…

Drug Manufacturers - Specialty & Generic
US, Wixom [HQ]
Major Shareholders · Proxy Ben. Owners

Shareholders

Breakdown
Rockwell Medical, Inc. can't present any analysts estimates at the moment detail analysis.
Intraday
Shares Outstanding
32,318,800
Volume
197,412
Volume on Avg.
726,568
Beneficial Owners Beta
SEC Source
Owner Shares Equivalence - $2.09 per share Last Form/Filing Last Transaction
10% Holder
- No data -
Officers/Directors Below 10%
- No data -
End of RMTI's Analysis
CIK: 1041024 CUSIP: 774374300 ISIN: US7743743004 LEI: - UEI: -
Secondary Listings
RMTI has no secondary listings inside our databases.